Caricamento...
Evidence-based medicine and Management of Hepatocellular Carcinoma in Thalassemia
BACKGROUND: Hepatocellular carcinoma as a complication is linked to improved outcomes of thalassemia. MAIN BODY: Published data suggest an incidence of HCC in thalassemia of about 2%. However, since thalassemia is endemic in many under-developed countries where patients have not probably been screen...
Salvato in:
| Pubblicato in: | BMC Gastroenterol |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7724702/ https://ncbi.nlm.nih.gov/pubmed/33297979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-020-01542-2 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|